Adrenal Function Follow-Up After Prolonged Illness: Clinical Considerations and Guideline-Based Management

Abstract

Prolonged critical illness is increasingly recognized to have lasting effects on adrenal function, with implications for patient recovery and long-term health outcomes. This review synthesizes current research on the incidence, mechanisms, risk factors, clinical presentation, diagnostic approaches, and management strategies for adrenal dysfunction following extended illness. Emphasis is placed on evidence-based recommendations and practical guidance for healthcare professionals involved in the longitudinal care of these complex patients.

Introduction

Adrenal insufficiency and hypothalamic-pituitary-adrenal (HPA) axis dysregulation are well-documented complications in survivors of prolonged critical illness. As critical care medicine advances and patient survival improves, the identification, monitoring, and treatment of adrenal dysfunction in this population have become increasingly important. Understanding the pathophysiological mechanisms and clinical implications is vital for optimizing post-acute care and improving recovery trajectories.

Epidemiology / Disease Burden

Adrenal dysfunction after prolonged illness is not uncommon, with studies estimating prevalence rates ranging from 10% to 30% among survivors of critical care, particularly those requiring extended mechanical ventilation or vasoactive support. This prevalence varies depending on diagnostic criteria, patient population, and timing of assessment. The true burden is likely underestimated due to overlapping symptoms with post-intensive care syndrome (PICS) and under-recognition in routine follow-up. Adrenal insufficiency in this context is associated with delayed recovery, increased re-hospitalization rates, and higher mortality, highlighting the need for systematic evaluation in this high-risk group.

Pathophysiology

The pathophysiology of adrenal dysfunction post-critical illness is multifactorial. Prolonged stress induces sustained activation of the HPA axis, often followed by a maladaptive downregulation upon recovery, termed \"critical illness-related corticosteroid insufficiency\" (CIRCI). Mechanisms include impaired hypothalamic or pituitary signaling, direct adrenal cortical suppression (potentially from exogenous corticosteroids or sepsis), and altered peripheral glucocorticoid metabolism. Cytokine-mediated inflammation and oxidative stress further disrupt adrenal steroidogenesis. Additionally, chronic illness may induce atrophy of the adrenal cortex, reducing reserve capacity and impairing response to subsequent physiologic stressors.

Risk Factors

Recognized risk factors for post-illness adrenal dysfunction include prolonged ICU stay, sepsis or septic shock, administration of high-dose or extended-course corticosteroids, traumatic brain injury, major surgery, and underlying autoimmune or infiltrative diseases. Patients with severe COVID-19, polytrauma, or chronic comorbidities such as diabetes and chronic kidney disease are at particularly high risk. Genetic predisposition and age-related decline in HPA axis resilience may also contribute, warranting heightened vigilance in elderly or immunocompromised individuals.

Clinical Features

The clinical manifestations of adrenal insufficiency after critical illness are often non-specific and overlap with other sequelae of prolonged hospitalization. Symptoms may include persistent fatigue, muscle weakness, anorexia, weight loss, hypotension (especially orthostatic), hyponatremia, and neuropsychiatric symptoms such as depression or cognitive impairment. In severe cases, patients may present with adrenal crisis, characterized by refractory hypotension, shock, and electrolyte disturbances. Differentiating these features from other causes of post-ICU morbidity is essential for timely diagnosis and intervention.

Diagnosis

Definitive diagnosis of adrenal insufficiency requires careful clinical assessment and biochemical testing. Baseline morning serum cortisol measurement is a useful initial screen, but dynamic testing (e.g., standard or low-dose ACTH stimulation test) is often necessary for confirmation. Interpretation of results must consider the confounding effects of altered cortisol-binding globulin, concurrent medications, and the recovery phase after critical illness. Guidelines recommend evaluating adrenal function in patients with persistent unexplained symptoms or those at high risk based on clinical course and exposure history. Additional tests to assess pituitary reserve and autoimmune markers may be indicated in select cases.

Treatment & Management

Management of post-illness adrenal insufficiency centers on tailored glucocorticoid replacement, typically with hydrocortisone in physiological doses, aiming to restore normal circadian rhythms and minimize adverse effects. Mineralocorticoid replacement is reserved for cases of primary adrenal failure. Education on stress-dose steroids during intercurrent illness or surgery is critical to prevent adrenal crisis. Regular monitoring of clinical response, serum electrolytes, and signs of overtreatment is necessary. Multidisciplinary collaboration with endocrinology, primary care, and rehabilitation teams enhances outcomes and quality of life for affected patients.

Recent Advances / Emerging Therapies

Recent research has focused on refining diagnostic criteria for CIRCI and exploring biomarkers that better predict adrenal recovery. Novel assays measuring free cortisol and advanced adrenal imaging techniques offer promise in improving diagnostic accuracy. Emerging therapies under investigation include selective glucocorticoid receptor modulators and adjunctive agents that modulate HPA axis recovery. There is growing interest in personalized approaches based on genetic and molecular profiling to stratify risk and guide follow-up intensity.

Guideline Recommendations

Consensus guidelines from the Society of Critical Care Medicine and the Endocrine Society emphasize the need for structured follow-up of adrenal function in survivors of critical illness, especially those with risk factors or persistent symptoms. Recommendations include early identification, prompt initiation of appropriate glucocorticoid therapy, patient education, and periodic reassessment. Multidisciplinary post-ICU clinics play a pivotal role in implementing these recommendations and ensuring comprehensive care.

Conclusion

Adrenal dysfunction is a significant yet under-recognized complication in the aftermath of prolonged critical illness. Timely recognition, accurate diagnosis, and evidence-based management are essential in optimizing recovery and preventing adverse outcomes. Ongoing research and evolving guidelines continue to inform best practices, underscoring the importance of a proactive, multidisciplinary approach in the follow-up of these vulnerable patients.